Our data point to at least two distinct pathways leading to worse outcome of LADC in elderly patients: (1) a shift in the CD4/CD8 T-cell ratio, and (2) PD-L1 expression ≥1% tumor cells combined with a low CD8+ or CD33+ cell density and a high CD4+ cells. Here, CD33 is linked to neoplasm.